AI assistant
Sending…
Cryoport, Inc. — Director's Dealing 2023
Mar 24, 2023
32876_dirs_2023-03-24_9cf555d8-b5a4-4363-a570-bb66eb4ed282.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2023-03-22
Reporting Person: STEFANOVICH ROBERT (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-22 | Common Stock | A | 10455 | — | Acquired | 107150 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-22 | Stock Option (right to buy) | $23.78 | A | 20910 | Acquired | 2030-03-22 | Common Stock (20910) | Direct |
Footnotes
F1: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024.
F2: 1/48 of options vest on the 22nd of each month for forty-eight months beginning 4/22/2023.
More from Cryoport, Inc.
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18